Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: The GLADAR experience

Journal of Clinical Rheumatology

Volumn 18, Issue 7, 2012, Pages 327-335

  Cardiel, Mario H ^a   Pons Estel, Bernardo A ^b   Sacnun, Mónica P ^b   Wojdyla, Daniel ^c   Saurit, Verónica ^d   Marcos, Juan Carlos ^e   Pinto, María Raquel C ^f   Cordeiro De Azevedo, Ana Beatriz ^g   Da Silveira, Inês Guimarães ^h   Radominski, Sebastião C ⁱ   Ximenes, Antônio C ^j   Massardo, Loreto ^k   Ballesteros, Francisco ^l   Rojas Villarraga, Adriana ^m   Oñate, Rafael Valle ⁿ   Hernandez, Margarita Portela ^o   Esquivel Valerio, Jorge A ^p   García De La Torre, Ignacio ^q   Khoury, Vianna J ^r   Millán, Alberto ^s   Soriano, Enrique Roberto ^t   more..

^a HOSPITAL GENERAL DR MIGUEL SILVA   (Mexico)

^b Hospital Provincial de Rosario   (Mexico)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^d HOSPITAL PRIVADO   (Argentina)

^e HOSPITAL SAN MARTÍN   (Argentina)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^h PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

ⁱ FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^j Hospital Geral de Goi nia Dr Alberto Rassi   (Brazil)

^k PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^l HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^m Clínica Universitaria Bolivarian ^*  (Colombia)

ⁿ HOSPITAL MILITAR CENTRAL   (Colombia)

^o HOSPITAL DE ESPECIALIDADES   (Mexico)

^p HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^q SECRETARÍA DE SALUD   (Mexico)

^r Hospital Presidente Estrella Urena   (Chile)

^s HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^t HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

more..

Author keywords

corticosteroids; disease modifying antirheumatic drugs; rheumatoid arthritis; treatment

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DATA BASE; DISEASE COURSE; DISEASE REGISTRY; DRUG USE; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; X RAY;

ADULT; ANTIMALARIALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOXAZOLES; LATIN AMERICA; MALE; METHOTREXATE; MIDDLE AGED; REGISTRIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 84867803697     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31826d6610     Document Type: Article

References (27)

1. Puolakka K, Kautianinen H, Mö ttönen T, et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis. Arthritis Rheum. 2004;50:55-62. (Pubitemid 38084287)
2. Nell VPK, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patient with early rheumatoid arthritis. Rheumatology. 2004;43:906-914. (Pubitemid 38996967)
3. Boers M. Understanding the window of opportunity concept in early arthritis. Arthritis Rheum. 2003;48:1771-1774. (Pubitemid 36828668)
4. Rheumatoid Arthritis: National Clinical Guideline for Management and Treatment in Adults. National Collaborating Centre for Chronic Conditions (UK). London: Royal College of Physicians (UK); 2009. National Institute for Health and Clinical Excellence: Guidance.
5. Katchamart W, Bourré-Tessier J, Donka T, et al. Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis. J Rheumatol. 2010;37:1422-1430.
6. Helfenstein M Jr, Halpern AS, Bertolo MB. Investigation on Brazilian clinical practices in rheumatoid arthritis: the Brazilian Rheumatoid Arthritis Clinical Practices Investigation-BRACTICE. J Clin Rheumatol. 2011;17(4 suppl 1):S1YS10.
7. Cardiel MH, Latin American Rheumatology Associations of the Pan-American League of Associations for Rheumatology (PANLAR), Grupo Latinoamericano de Estudio de Artritis Reumatoide (GLADAR). First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology (Oxford). 2006;(45 suppl 2):ii7Yii22. (Pubitemid 44445097)
8. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324. (Pubitemid 18091653)
9. Arthros 6.0. http://www.arthrosoft.com/sp/public-s.html. Accessed September 12, 2012.
10. Pons-Estel BA,Catoggio LJ, Cardiel MH, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among " Hispanics". Medicine (Baltimore). 2004;83:1-17. (Pubitemid 38124852)
11. Hetland ML, Lindegaard HM, Hansen A, et al. Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry. Ann Rheum Dis. 2008;7:1023-1026. (Pubitemid 351956667)
12. Kiely P, Williams R, Walsh D, et al. Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort. Rheumatology. 2009;48:57-60.
13. Pope JE, Hong P, Koehler BE. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists. J Rheumatol. 2002;29:255-260. (Pubitemid 34118769)
14. Hjardem E, Hetland ML,Stergaard M, et al. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of marketing use in Denmark and Norway: criteria are becoming less stringent. Ann Rheum Dis. 2005;64:1220-1223. (Pubitemid 41113362)
15. Goycochea MV, Arce CA, Guzmán S, et al. Prescription rheumatology practices among Mexican specialists. Arch Med Res. 2007;38: 354-359.
16. Benhamou M, Rincheval N, Roy C, et al. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort. J Rheumatol. 2009;152:2490-2496.
17. Korpela M, Laasonen L, Hannonen P, et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs. Arthritis Rheum. 2004;50:2072-2081. (Pubitemid 38924384)
18. Bakker MF, Jacobs JW, Welsing PM, et al. Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study. Ann Rheum Dis. 2011;70:1099-1103.
19. Lukas C, Combe B, Ravaud P, et al. Favorable effect of very early DMARD treatment on radiographic progression in early inflammatory arthritis: data from the É tude et Suivi des polyarthrites indifférenciées récentes (study and follow-up of early undifferentiated polyarthritis). Arthritis Rheum. 2011;63:1804-1811.
20. Schipper LG, Kievit W, den Broeder AA, et al. Treatment strategies aiming at remission in early rheumatoid arthritis patients: starting with methotrexate monotherapy is cost-effective. Rheumatology. 2011;50:1320-1330.
21. Weng HH, Ranganath VK, Khanna D, et al. Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis. J Rheumatol. 2010;37:550-557.
22. Saevarsdottir S,Wallin H, Seddighzadeh M, et al. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis. 2011;70:469-475.
23. Cronstein BN. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev. 2005;57:163-172. (Pubitemid 41043882)
24. Pincus T, Yazici Y, Sokka T, et al. Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol. 2003;21:179-185.
25. Wassenberg S, Rau R, Steinfeld P, et al. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years. Arthritis Rheum. 2005;52:3371-3380.
26. Kirwan JR, Bijlsma JW, Boers M, et al. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev. 2007;24:CD006356. Review.
27. Massardo L, Suárez-Almazor ME, Cardiel MH, et al. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano de Estudio de Artritis Reumatoide. J Clin Rheumatol. 2009;15:203-210.